Tag: CAPItello-291

Treatment options beyond CDK4/6 inhibition

Presented By

Dr Erica Mayer (Dana-Farber Cancer Institute, MA, USA); Prof. Virginia Kaklamani (University of Texas Health Sciences Center, TX, USA);

Trial

PACE; EMERALD; SERENA-2; CAPItello-291; VERITAC

Conference

SABCS 2022

Type

Peer-reviewed article